SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-023369
Filing Date
2020-08-25
Accepted
2020-08-25 16:30:50
Documents
1
Period of Report
2020-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9112
  Complete submission text file 0000899243-20-023369.txt   10491
Mailing Address 15001 BARNHARDT CT CHAPEL HILL NC 27517
Business Address
Hall Steven Edward (Reporting) CIK: 0001602732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 201132618

Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)